Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Her doctor prescribed the cheaper, generic version of the weight-loss drug after her insurer ... to stop making compounded ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound ... OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription medication created ...

Zepbound is an injectable prescription medication created to help adults with obesity and weight-related problems ... for savings programs. The FDA's approval of Zepbound provides a new approach ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do not inform patients of the risks associated with these medicines, according ...